Literature DB >> 19364876

Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

Johann D D Pitout1, Lorraine Campbell, Deirdre L Church, Daniel B Gregson, Kevin B Laupland.   

Abstract

Extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli has recently emerged as a major risk factor for community-acquired, travel-related infections in the Calgary Health Region. Molecular characterization was done on isolates associated with infections in returning travelers using isoelectric focusing, PCR, and sequencing for bla(CTX-M)s, bla(TEM)s, bla(SHV)s, bla(OXA)s, and plasmid-mediated quinolone resistance determinants. Genetic relatedness was determined with pulsed-field gel electrophoresis using XbaI and multilocus sequence typing (MLST). A total of 105 residents were identified; 6/105 (6%) presented with hospital-acquired infections, 9/105 (9%) with health care-associated community-onset infections, and 90/105 (86%) with community-acquired infections. Seventy-seven of 105 (73%) of the ESBL-producing E. coli isolates were positive for bla(CTX-M) genes; 55 (58%) produced CTX-M-15, 13 (14%) CTX-M-14, six (6%) CTX-M-24, one (1%) CTX-M-2, one (1%) CTX-M-3, and one (1%) CTX-M-27, while 10 (10%) produced TEM-52, three (3%) TEM-26, 11 (11%) SHV-2, and four (4%) produced SHV-12. Thirty-one (30%) of the ESBL-producing E. coli isolates were positive for aac(6')-Ib-cr, and one (1%) was positive for qnrS. The majority of the ESBL-producing isolates (n = 95 [90%]) were recovered from urine samples, and 83 (87%) were resistant to ciprofloxacin. The isolation of CTX-M-15 producers belonging to clone ST131 was associated with travel to the Indian subcontinent (India, Pakistan), Africa, the Middle East, and Europe, while clonally unrelated strains of CTX-M-14 and -24 were associated with travel to Asia. Our study suggested that clone ST131 coproducing CTX-M-15, OXA-1, TEM-1, and AAC(6')-Ib-cr and clonally unrelated CTX-M-14 producers have emerged as important causes of community-acquired, travel-related infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364876      PMCID: PMC2687226          DOI: 10.1128/AAC.00061-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

2.  Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand.

Authors:  Joshua T Freeman; Stephen J McBride; Helen Heffernan; Tracy Bathgate; Chris Pope; Roderick B Ellis-Pegler
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

3.  CTX-M-15-producing Shigella sonnei strain from a Czech patient who traveled in Asia.

Authors:  Jaroslav Hrabák; Joanna Empel; Marek Gniadkowski; Zbynek Halbhuber; Karel Rébl; Pavla Urbásková
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

4.  Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines.

Authors:  Nashwan Al Naiemi; Bastiaan Zwart; Martine C Rijnsburger; Robert Roosendaal; Yvette J Debets-Ossenkopp; Janet A Mulder; Cees A Fijen; Willemina Maten; Christina M Vandenbroucke-Grauls; Paul H Savelkoul
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

5.  Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Authors:  Zeki Yumuk; Gokhan Afacan; Marie-Hélène Nicolas-Chanoine; Albert Sotto; Jean-Philippe Lavigne
Journal:  J Antimicrob Chemother       Date:  2008-05-02       Impact factor: 5.790

6.  Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr.

Authors:  Johann D D Pitout; Yi Wei; Deirdre L Church; Daniel B Gregson
Journal:  J Antimicrob Chemother       Date:  2008-02-21       Impact factor: 5.790

7.  Quinolone resistance among Shigella spp. isolated from travellers returning from India.

Authors:  L Mensa; F Marco; J Vila; J Gascón; J Ruiz
Journal:  Clin Microbiol Infect       Date:  2007-12-08       Impact factor: 8.067

8.  Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance.

Authors:  Sundeep K Gupta; Felicita Medalla; Michael W Omondi; Jean M Whichard; Patricia I Fields; Peter Gerner-Smidt; Nehal J Patel; Kara L F Cooper; Tom M Chiller; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

9.  Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin.

Authors:  Mark R Sannes; Edward A Belongia; Burney Kieke; Kirk Smith; Amy Kieke; Mary Vandermause; Jeff Bender; Connie Clabots; Patricia Winokur; James R Johnson
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

10.  Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.

Authors:  Richard Colgan; James R Johnson; Michael Kuskowski; Kalpana Gupta
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

View more
  25 in total

1.  Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand.

Authors:  J T Freeman; D A Williamson; H Heffernan; M Smith; J E Bower; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-23       Impact factor: 3.267

Review 2.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.

Authors:  E Ruppé; A Pitsch; F Tubach; V de Lastours; F Chau; B Pasquet; J-C Lucet; A Andremont; B Fantin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

Review 5.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Authors:  Joanne L Platell; Rowland N Cobbold; James R Johnson; Anke Heisig; Peter Heisig; Connie Clabots; Michael A Kuskowski; Darren J Trott
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

7.  The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam.

Authors:  Nhu Thi Khanh Nguyen; Vinh Ha; Nga Vu Thieu Tran; Richard Stabler; Duy Thanh Pham; Thi Minh Vien Le; H Rogier van Doorn; Ana Cerdeño-Tárraga; Nicholas Thomson; James Campbell; Van Minh Hoang Nguyen; Thi Thu Nga Tran; Minh Van Pham; Thuy Thu Cao; Brendan Wren; Jeremy Farrar; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

8.  Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Johann Dd Pitout
Journal:  F1000 Med Rep       Date:  2009-11-16

9.  Escherichia coli ST131: variations on a theme of clonal expansion.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-03-06       Impact factor: 1.731

10.  Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.

Authors:  Johann D D Pitout; Daniel B Gregson; Lorraine Campbell; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.